Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
featured
Published in Cardiology

Journal Scan / Research · January 16, 2014

Periprocedural Anticoagulation With Uninterrupted Rivaroxaban in Patients Undergoing RFA for Atrial Fibrillation

Journal of the American College of Cardiology

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Jason Garlie MD

Journal of the American College of Cardiology
Feasibility and Safety of Uninterrupted Rivaroxaban for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation: Results From a Multicenter Prospective Registry
J Am Coll Cardiol 2014 Jan 08;[EPub Ahead of Print], D Lakkireddy, YM Reddy, L Di Biase, A Vallakati, MC Mansour, P Santangeli, S Gangireddy, V Swarup, F Chalhoub, D Atkins, S Bommana, MPA Verma, JE Sanchez, JD Burkhardt, CD Barrett, S Baheiry, J Ruskin, V Reddy, A Natale

Further Reading

Most Read This Week

Recently Updated